ClinicalTrials.gg
CompletedNCT07948785Updated Nov 19, 2026

Identifying High Risk Factors and Predictive Model Development for Acute DWI-ADC Microinfarctions Following Endovascular Treatment of Unruptured Intracranial Aneurysms Using Thromboelastography (TEG) and Multimodal Data Analysis.

An interventional study of FD stent and Stent assisted coiling (SAC) in Unruptured Intracranial Aneurysm, sponsored by The First Affiliated Hospital with Nanjing Medical University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by The First Affiliated Hospital with Nanjing Medical University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jun 2025, registered Nov 2026).
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
602
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 100 studies in Intracranial Aneurysm with a site in China — 38 open to participants now, 42 under way, 1 of them phase 3. Intracranial Aneurysm · China.

Enrollment
7th of 49
602 · median 188
Started
2025
with 6 others
No phase
37 of 100
13 open now
Registered
100th of 100
by date
Lead sponsor
5 of 100
The First Affiliated Hospital with Nanjing Medical University

Among the 100 studies in Intracranial Aneurysm with a site in China, this one is the 7th largest by enrollment of the 49 interventional ones that give a count, is one of 7 that started in 2025, is one of 37 with no phase, and was the 100th registered.

Intracranial Aneurysm

419 studies on the registry are indexed under Intracranial Aneurysm; 118 are open to participants now.

Browse Intracranial Aneurysm studies →

Open to participants now

38 of the 100 studies in Intracranial Aneurysm with a site in China are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 84 Intracranial Aneurysm studies recruiting now, 50 (60%) set no upper age limit and 15 (18%) stop at 75 or younger; 16 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 100 studies in Intracranial Aneurysm with a site in China, or all of them as a file.
02

Study summary

  1. Disease Description:

    Postoperative diffusion weighted imaging (DWI)- apparent diffusion coefficient (ADC) microinfarctions are commonly detected after endovascular intervention or surgical clipping of Unruptured Intracranial Aneurysms. Acute postoperative DWI-ADC microinfarctions are increasingly recognized as a cause of subtle neurological deficits.

  2. Intervention Description:

    Preoperative TEG parameters (R time, K time, α-angle, MA, LY30) and aneurysm morphological indices (size, neck width, location, and irregularity) were analyzed by CTA/DSA. Additionally, demographic and clinical information, procedural outcomes, and follow-up results were recorded systematically. Postoperative DWI-ADC MRI was performed within 72 hours to detect new ischemic micro lesions. The primary outcome was presence of new postoperative microinfarctions on DWI-ADC. Univariate analyses compared groups with and without microinfarction.

  3. Research Hypothesis:

The relationship between perioperative coagulation dynamics, aneurysm morphology, and risk of acute postoperative DWI-ADC microinfarctions remains unclear. Maybe the findings could potentially provide a personalized risk assessment framework for perioperative management and prospective interventional studies.

03

Conditions studied

  • Unruptured Intracranial Aneurysm

Browse trials for

Keywords

  • Acute postoperative DWI-ADC microinfarctions
  • Thromboelastography (TEG)
  • Unruptured intracranial aneurysms (UIA)
  • MRI-DWI-ADC
  • machine learning (ML)
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All UIA patients, age ≥18 years, treated with endovascular embolization, with complete medical records were included.

Exclusion criteria

Exclusion Criteria:

  • Cases of patients with ruptured aneurysms, missing data or pre-existing conditions that could confound the analysis such as prior stroke or intracranial hemorrhage, arteriovenous malformations, arteriovenous fistulas, or Moyamoya disease; the presence of severe stenosis in the parent artery, active infections, or any hematologic diseases were excluded. was waived owing to the retrospective nature of the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
602 participants (actual)

Study arms

  • Experimental
    FD

    UIA patients are treated using an FD/SAC 1/2 days after doing their TEG analysis.

    Procedure: FD stent

  • Experimental
    SAC

    UIA patients are treated using an SAC 1/2 days after doing their TEG analysis.

    Procedure: Stent assisted coiling (SAC)

Interventions

  • ProcedureFD stent

    UIA patients will be treated using an FD during endovascular embolization 1/2 days after doing their TEG analysis.

  • ProcedureStent assisted coiling (SAC)

    UIA patients will be treated using an stent assisted coiling (SAC) during endovascular embolization 1/2 days after doing their TEG analysis.

06

What researchers measure

Primary outcomes

  1. Number of Participants with new acute postoperative DWI-ADC microinfarctions within 72h after the procedure.

    The occurrence of new postoperative MRI-DWI-ADC lesions consistent with acute postoperative microinfarctions detected on MRI-DWI-ADC within 48 hours of intervention

    Time frame: 72 hours after the endovascular intervention (UIA embolization)

07

Study locations

1 site
  • Jiangsu Province People's Hospital the First Affiliated Hospital of Nanjing Medical University
    Nanjing, Jiangsu 210029, China
08

References and documents

Publications

  • Sakayori T, Nakanishi R, Shoda K, Ueno Y, Kanbe A, Oka A, Mizutani D, Kitano K, Kikuchi R, Enomoto Y. Comparative study of four platelet function tests conducted using two systems in neuroendovascular patients. Sci Rep. 2025 Sep 29;15(1):33437. doi: 10.1038/s41598-025-19061-z. PubMed 41023057 ↗
  • Iosif C, Camilleri Y, Saleme S, Caire F, Yardin C, Ponomarjova S, Boncoeur-Martel MP, Mounayer C. Diffusion-weighted imaging-detected ischemic lesions associated with flow-diverting stents in intracranial aneurysms: safety, potential mechanisms, clinical outcome, and concerns. J Neurosurg. 2015 Mar;122(3):627-36. doi: 10.3171/2014.10.JNS132566. Epub 2015 Jan 6. PubMed 25559933 ↗
  • Pierot L, Rouchaud A, Chabert E, Desal H, Ricolfi F, Barbe C, Soize S, Zerroug A, Eugene F, Clarencon F, Ferre JC. Endovascular treatment of unruptured intracranial aneurysms: Rate of thromboembolic events depicted by diffusion-weighted imaging in relation to different techniques. J Neurointerv Surg. 2025 Aug 13;17(9):949-955. doi: 10.1136/jnis-2024-022051. PubMed 39095086 ↗
  • Park JC, Lee DH, Kim JK, Ahn JS, Kwun BD, Kim DY, Choi CG. Microembolism after endovascular coiling of unruptured cerebral aneurysms: incidence and risk factors. J Neurosurg. 2016 Mar;124(3):777-83. doi: 10.3171/2015.3.JNS142835. Epub 2015 Sep 18. PubMed 26381257 ↗
  • Raj R, Numminen J, Niemela M, Korja M. Technique and device specific diffusion-weighted imaging detected ischemic lesions and occlusion outcomes in endovascular treatment of unruptured aneurysms. Acta Neurochir (Wien). 2026 Jun 4;168(1):182. doi: 10.1007/s00701-026-06934-z. PubMed 42240692 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Jun 2026, 11 months.

Of 59 non-industry interventional studies with no phase under Intracranial Aneurysm, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 134. This study's 11 months is below that.

Counting every sponsor, half of 106 studies reached it within 39 months; a quarter within 22 and three quarters within 69.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 19, 2026
StartActual
Jun 23, 2025
Primary completionActual
Jun 15, 2026
CompletionActual
Jun 15, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948785
Responsible party
Lu Hua (Professor, The First Affiliated Hospital with Nanjing Medical University) — Principal investigator
First posted
Nov 19, 2026
Start date
Jun 23, 2025
Primary completion
Jun 15, 2026
Completion
Jun 15, 2026
Last update
Nov 19, 2026

Study contacts

Hua Lu, PhD
principal investigator · Jiangsu Province People's Hospital the First Affiliated Hospital of Nanjing Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion